|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 119.60 GBX | -1.16% |
|
-3.08% | -4.32% |
| 07-13 | PureTech Health announces first patient dosing in Celea phase 3 trial | AN |
| 07-13 | PureTech Health: Celea Therapeutics Kicks Off Late-stage Trial for Idiopathic Pulmonary Fibrosis Drug | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.16% | -3.08% | -12.95% | -6.27% | -4.32% | -17.40% | -46.49% | -62.80% | -19.05% | 391M | |
| -0.80% | +6.30% | +5.67% | +20.30% | +6.02% | -1.72% | +13.00% | -17.67% | +212.10% | 48.95B | |
| -3.86% | +15.22% | +23.62% | +50.83% | +5.97% | +24.71% | +6.75% | -3.57% | +203.86% | 40.75B | |
| +2.67% | +1.96% | +2.76% | +33.53% | +141.62% | +419.92% | +633.14% | +571.96% | - | 38.46B | |
| -11.33% | -1.21% | +13.28% | +9.32% | +6.25% | +7.62% | +50.69% | +1.96% | +1,144.89% | 36.38B | |
| +5.56% | +11.70% | +6.03% | -2.21% | +10.22% | +11.64% | +51.50% | -11.63% | +159.73% | 28.45B | |
| +0.76% | -1.94% | -7.11% | +8.01% | - | - | - | - | - | 16.62B | |
| -4.22% | -4.13% | +9.66% | +38.72% | +3.40% | +32.66% | +129.40% | +230.10% | - | 16.33B | |
| -10.09% | -3.21% | -5.10% | +39.31% | -9.54% | -9.18% | -34.43% | -32.24% | +114.17% | 13.65B | |
| -0.06% | -2.81% | +0.62% | +19.22% | +9.94% | +3.16% | +10.08% | -30.88% | +104.50% | 13.56B | |
| +1.02% | +2.64% | +3.77% | +40.95% | +17.98% | +33.57% | +12.31% | -42.17% | +166.10% | 11.31B | |
| +3.63% | +0.36% | +1.95% | +30.21% | +22.48% | +24.81% | -13.63% | -40.25% | +153.23% | 11.22B | |
| +0.09% | -5.98% | +30.25% | +16.04% | -9.88% | +79.64% | +517.88% | +258.68% | +2,514.46% | 10.63B | |
| +0.01% | -0.01% | +1.14% | +61.95% | +77.85% | +256.93% | +527.30% | - | - | 10.08B | |
| -3.25% | -9.43% | +25.03% | +21.04% | +26.66% | +9.65% | +37.29% | -61.23% | - | 9.18B | |
| +2.54% | -4.32% | -32.58% | -28.50% | -32.43% | +23.25% | +29.02% | +43.93% | +40.63% | 8.93B | |
| +31.45% | +2.50% | +13.25% | +40.26% | +58.94% | +154.16% | +615.57% | +180.84% | - | 8.55B | |
| -1.15% | -0.06% | +5.95% | +19.79% | -12.49% | -22.18% | -20.73% | -29.70% | +33.35% | 8.65B | |
| +6.43% | -2.65% | -6.29% | +32.55% | +38.11% | +143.84% | +391.13% | +78.56% | - | 8.66B | |
| +2.39% | -5.19% | -4.15% | +48.98% | +79.49% | +79.81% | +71.52% | +94.12% | +1.33% | 8.11B | |
| Average | +0.05% | +2.04% | +3.74% | +24.70% | +22.96% | +66.05% | +156.91% | +62.67% | +371.48% | 17.44B | |
| Weighted average by Cap. | +0.27% | +4.98% | +6.84% | +25.57% | +27.16% | +76.86% | +152.89% | +86.88% | +410.19% |
- Stock Market
- Stocks
- PRTC Stock
- Sector PureTech Health plc
Select your edition
All financial news and data tailored to specific country editions
